Doctors & patients are saying about 'A-Fib.com'...


"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."

Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN

"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."

Jill and Steve Douglas, East Troy, WI 

“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP. 

Faye Spencer, Boise, ID, April 2017

“I think your site has helped a lot of patients.”

Dr. Hugh G. Calkins, MD  Johns Hopkins,
Baltimore, MD


Doctors & patients are saying about 'Beat Your A-Fib'...


"If I had [your book] 10 years ago, it would have saved me 8 years of hell.”

Roy Salmon, Patient, A-Fib Free,
Adelaide, Australia

"This book is incredibly complete and easy-to-understand for anybody. I certainly recommend it for patients who want to know more about atrial fibrillation than what they will learn from doctors...."

Pierre Jaïs, M.D. Professor of Cardiology, Haut-Lévêque Hospital, Bordeaux, France

"Dear Steve, I saw a patient this morning with your book [in hand] and highlights throughout. She loves it and finds it very useful to help her in dealing with atrial fibrillation."

Dr. Wilber Su,
Cavanaugh Heart Center, 
Phoenix, AZ

"...masterful. You managed to combine an encyclopedic compilation of information with the simplicity of presentation that enhances the delivery of the information to the reader. This is not an easy thing to do, but you have been very, very successful at it."

Ira David Levin, heart patient, 
Rome, Italy

"Within the pages of Beat Your A-Fib, Dr. Steve Ryan, PhD, provides a comprehensive guide for persons seeking to find a cure for their Atrial Fibrillation."

Walter Kerwin, MD, Cedars-Sinai Medical Center, Los Angeles, CA


Catheter Ablation for Atrial Fibrillation Prevents Recurrence Compared to Drugs

Several recent research trials and studies have demonstrated that up to 94% of patients with Atrial Fibrillation treated with catheter ablation are free from arrhythmia recurrence at one year.

And, with nearly one-half the chance of death, stroke, cardiac arrest, and cardiovascular hospitalization when compared to patients on antiarrhythmic drugs (AADs).

In addition, these studies show that catheter ablation could significantly improve patient quality-of-life versus a treatment strategy of drug therapy. (Also, ablation is a more cost-effective option over the long term.)

Recurrences Attributable to Comorbidities (Other Illnesses)

With so many catheter ablations for A-Fib being performed worldwide (some estimate over one million preformed last year), it’s inevitable that anecdotally you’ll hear of people having recurrences.

Comorbidities raise risk of A-Fib recurrence

Comorbidities raise risk of A-Fib recurrence

But recurrences are often attributable to comorbidities such as diabetes, sleep apnea, high blood pressure, obesity, etc.

For example, if you come in with sleep apnea, some centers won’t allow you to have a catheter ablation till you get the sleep apnea problem under control, because of the threat of recurrence.

To lower your risk of recurrence after a successful ablation, aim to avoid other health problems. Address your sleep apnea. Lose weight and/or maintain a healthy weight. Stay fit, eat a healthy diet and limit alcohol consumption. These life choices can reduce the risk of developing high blood pressure and diabetes.

Staying in generally good health (and avoiding comorbidities) will lower your risk of recurrence of your A-Fib.

Why Not to Fear Recurrence: Consider a Worst-Case Scenario

For a moment, let’s discuss a worst-case scenario. At age 60 you are diagnosed with Lone A-Fib (no comorbidities) and have a catheter ablation which makes you A-Fib free.

It lasts 10 years. But think. For all those 10 years, you’ve know what a blessing it is being in normal sinus rhythm (NSR).

If your A-Fib recurs it’s not the end of the world. You and your doctor will deal with it.

Then, at age 70, your A-Fib returns. After a short touch-up ablation (which probably filled in some gaps that appeared in the ablation lines), you’re once again A-Fib free. And, you will probably live in normal sinus for the rest of your life.

(This scenario worked out pretty well, don’t you think.) If your A-Fib recurs it’s not the end of the world. You and your doctor will deal with it.

For A-Fib Patients Reluctant About Catheter Ablation

The track record for successful catheter ablation to treat Atrial Fibrillation is impressive. And continues to outperform treatment with antiarrhythmic drugs (AADs).

While recurrence does happen, it’s mostly after years of living A-Fib free in normal sinus rhythm. If that happens, often it only requires a “touch-up” ablation to get back once again in normal sinus rhythm.

It makes no sense to not have a catheter ablation because of some remote possibility you might have a recurrence!

On a Personal Note

My 21-year Catheter Ablation ‘Warranty’ Ran Out! 

My A-Fib returned in Sept. 2018. Recurrence didn’t come as much of a surprise. Back in 1998 my ablation was primitive compared to what EPs are doing today. They actually ablated inside just one of my pulmonary veins (PVs) to eliminate the A-Fib signal source. -> Read how Steve Ryan’s became A-Fib-free again.

Resource for this article

• Biosense Webster, Inc. Announces Catheter Ablation May Be up to 10 Times More Effective Than Standard Drug Therapy Alone at Delaying Progression of Atrial Fibrillation. October 3, 2019. ESC Congress

• ESC 2019: Catheter ablation may be up to 10 times more effective than drug therapy alone at delaying AF progression. Cardiac Rhythm News. 2nd September 2019. https://tinyurl.com/25xykh3k

• Philips, T. et al. Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol. https://pubmed.ncbi.nlm.nih.gov/29315411/ doi: 10.1093/europace/eux376

• Johnson &Johnson, October 3, 2019. Biosense Webster, Inc. Announces Catheter Ablation May Be up to 10 Times More Effective Than Standard Drug Therapy Alone at Delaying Progression of Atrial Fibrillation. https://tinyurl.com/4n7xdsh5

Additional Sources:

• Hussein A, et al. Prospective use of Ablation Index targets improves clinical outcomes following ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2017. 28 (9): 1037-1047.

• Taghji P, et al. Evaluation of a Strategy Aiming to Enclose the Pulmonary Veins With Contiguous and Optimized Radiofrequency Lesions in Paroxysmal Atrial Fibrillation: A Pilot Study. JACC Clin Electrophysiol 2018. 4 (1): 99-108.

• Phlips T, et al. Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol. Europace 2018. 20. (FI_3): f419-f427.

• Solimene F, et al. (2019) Safety and efficacy of atrial fibrillation ablation guided by Ablation Index module. J Interv Card Electrophysiol 2019. 54 (1): 9-15.

• Di Giovanni G, et al. One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon. J Cardiovasc Electrophysiol 2014. 25 (8): 834-839.

• Jourda F, et al. Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation. Europace 17 2015. (2): 225-231.

• Lemes C, et al. One-year clinical outcome after pulmonary vein isolation in persistent atrial fibrillation using the second-generation 28 mm cryoballoon: a retrospective analysis. 2016. Europace 18 (2): 201-205.

• Guhl EN, et al. Efficacy of Cryoballoon Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation. J Cardiovasc Electrophysiol 2016. 27 (4): 423-427.

• Irfan G,  et al. One-year follow-up after second-generation cryoballoon ablation for atrial fibrillation in a large cohort of patients: a single-centre experience. 2016 Europace 18 (7): 987-993.

• Boveda S, et al. Single-Procedure Outcomes and Quality-of-Life Improvement 12 Months Post-Cryoballoon Ablation in Persistent Atrial Fibrillation: Results From the Multicenter CRYO4PERSISTENT AF Trial. JACC Clin Electrophysiol 2018.  4 (11): 1440-1447

Research: Catheter Ablation for Atrial Fibrillation Lowers Risk of Dementia

In an important study from South Korea, researchers found that patients undergoing a successful catheter ablation for A-Fib had a reduced risk of dementia. Previous research had shown that A-Fib was linked to an increased risk of dementia.

Sinus Rhythm Reduces Dementia

Intuitively one would think that going from A-Fib to normal sinus rhythm would increase and improve blood flow to the brain, thereby improving brain function. And indeed, in this retrospective study, catheter ablation reduced the incidence of dementia by nearly a third (27%) compared to those who tried to control their A-Fib with medication alone.

Alzheimer’s disease is one type of dementia.

Using data from South Korea’s National Health Insurance Service, they identified 9,119 patients who had ablation and 17,978 who received medical therapies. During the follow-up period (6-12 years) there were 164 cases of dementia in the ablation group and 308 cases in the medical therapy group. Ablation was linked to a 23% lower incidence of Alzheimer’s disease and a 50% decrease in vascular dementia compared to medical therapies.

Ablation was linked to a 23% lower incidence of Alzheimer’s disease and a 50% decrease in vascular dementia compared to medical therapies.

Ablation Reduced Dementia by 44%!

According to one of the lead researchers, Dr. Gregory Lip of the University of Liverpool (UK), “…successful ablation was significantly associated with a 44% reduced risk of dementia compared to medical therapy…”

Improved Blood Flow Reduces Alzheimer’s

What’s perhaps most important about this study is the reduced risk or incidence of Alzheimer’s disease after a successful catheter ablation for A-Fib. When people develop Alzheimer’s, it’s considered the end, that there’s very little that can be done to help these patients. But restoring blood flow to their brains seems to prevent or reduce Alzheimer’s.

Can we prevent or reduce Alzheimer’s by improving blood flow to the brain? Could these researchers have discovered a way to cure or improve Alzheimer’s? This could be ground-breaking research!

Resource for this article
Catheter ablation linked to lower incidence of dementia in AF patients, Cardiac Rhythm News. October 7, 2020. https://tinyurl.com/LowerDementia

AF Symposium ’21—New Report with Dr. Pierre Jais on Pulsed Electrical Field Ablation for Atrial Fibrillation

Pierre Jaïs, MD

My next report from the 2021 AF Symposium is on the short side.

Dr. Pierre Jais of the French Bordeaux Group (LIRYC) covers two topics; first, he briefly discusses pre-clinically testing of Pulsed Electrical Field ablation (PEF), Then he briefly covers the BEAT AF 5-year study which compares the effectiveness of PEF to standard RF ablation. Read it now, go to my report.

2021 AF Symposium Reports: More to Come

You’ll find my growing list of reports on the 2021 AF Symposium page. (You’ll find the link of the left menu of the website,)

As always, I write these summary reports to offer A-Fib.com readers the most up-to-date research and developments that may impact their treatment choices. All my reports are written in plain language for A-Fib patients and their families.

Help Prevent and Cure Heart Rhythm Diseases–Support the LIRYC Institute

The LIRYC Institute of Bordeaux, France, is asking for the support of our A-Fib.com readers. This institute is headed by Professor Michel Haissaguerre, who along with cardiology teams at the University Hospital of Bordeaux, France, is responsible for curing my A-Fib in 1998.
LIRYC stands for L’Institut de RYthmologie et Modélisation Cardiaque (in English: Electrophysiology and Heart Modeling Institute)

The LIRYC Institute: Entirely Dedicated to Heart Rhythm Disorders

Heart rhythm disorders affect millions of people worldwide and account for 30% of all cardiovascular disease, which is the leading cause of death in the world.

The LIRYC Institute is the only research, care, innovation and teaching Institute fully dedicated to heart rhythm disorders (atrial fibrillation, ventricular fibrillation and heart failure) arising from compromised electrical activity within the heart. It was established ten years ago in France to seek solutions to this major public health.

The Institute espouses a focused multi-disciplinary approach to understanding and treating these disorders. So far, this international team of experts has helped 400,000 patients worldwide suffering from atrial fibrillation. (Including Steve Ryan)

LIRYC Innovations

Entirely dedicated to heart rhythm disorders, LIRYC has chosen to focus on four distinct but interrelated objectives:

research to better understand the mechanisms underlying the disorders;

innovation to invent and develop the therapies of the future;

patient care to continue to improve patient management thus reducing morbidity and mortality rates;

training and education to promote and promulgate best practices for physicians and institutions around the world.

LIRYC Institute Capital Campaign: Supports the Prevention and Cure of Heart Rhythm Diseases

In 2020, LIRYC Institute launched a ten-million-euro capital campaign for the purpose of continuing and broadening the fight on the ravages caused by heart rhythm disorders.

LIRYC Institute is a 501c3 international Non-profit Organization.

Funds raised will be applied to underwriting new research projects and to the purchase of new technology as well as supporting educational and training programs for medical professionals across the globe.

Thanks to the generosity of donors, 35% of the goal has already achieved!

Consider Making a Donation to Support the LIRYC Effort

If you would like to help continue the fight to save lives lost to heart rhythm disorders, you can make a donation via the Friends of the LIRYC Foundation or email LIRYC directly at adele.lasne@ihu-liryc.fr or telephone +33 (0)5 35 38 19 97.

To read the LIRYC Mission and Key Areas of Focus, visit the LIRYC site (this is the English version)

You can also join the LIRYC community on Facebook and LinkedIn.

VIDEO: Mission of the LIRYC Institute (1:15)

My First Reports: 26th International AF Symposium 2021–A Virtual Experience

The 2021 AF Symposium was held from January 29-31. Because of the COVID-19 virus, the AF Symposium was virtual, streamed live with over 6,200 attendees. (That’s got to be some kind of a record!)

The AF Symposium is a major scientific forum at which health care professionals (and journalists, like me) have a unique opportunity to learn about advances in research and treatment of Atrial Fibrillation directly from leading medical scientists, clinicians and researchers.

If you are new to reading my reports and summaries from the AF Symposium, I recommend you look at: “What is the Annual ‘AF Symposium’ and Why it’s Important to Patients.”

My First Two Reports

As always, my reports will be written in plain language for A-Fib patients and their families.

Overview: 26th Annual International AF Symposium 2021–A Virtual Experience.

It’s a privilege to be able to attend presentations by the best clinicians and researchers working in A-Fib today. I learn more in three days than in a year of reading the various A-Fib research reports. Read my Overview of the 2021 AF Symposium.

Challenging Cases #1: “Torrential” Near Death Catheter Ablation Case

Challenging Cases is a popular forum where leading EPs talk frankly about their most difficult cases in past year. My first report is a near death catheter ablation complicated by the patient directive: in no case could blood transfusions be used. Read more.

Did you notice the new menu tab on the left? We’ve add: 2021 AF Symposium Reports. Click on the tab any time for a list of all my reports.

More of My Reports to Come

Look for more of my reports from the 2021 AF Symposium in the next weeks and months.

I will share the current state of the art in A-Fib research and treatments and what’s relevant to patients with Atrial Fibrillation.

Atrial Fibrillation and PVCs, How Do They Compare?

An A-Fib.com reader sent me an email asking about the difference between Atrial Fibrillation and PVCs. To start, PVC stands for Premature Ventricular Contraction.

What is a PVC?…

A Premature Ventricular Contraction (PVC) is like an extra beat or a missed beat that comes from the lower part of your heart, the ventricles. Not to worry. We all get them occasionally.

EKG showing a PVC spike; (source: Wikipedia)

EKG showing a PVC spike; (source: Wikipedia)

Surprisingly, PVCs can be a forecaster of A-Fib. In fact, PVCs can precede an episode or predict who will develop A-Fib.

…Compared to Atrial Fibrillation?

During A-Fib, the upper part of the heart, the atria, go crazy and start beating out of sync which causes the ventricles (the lower part) to beat irregularly.

(A-Fib is usually much more disturbing than an occasional PVC missed or early beat.)

However, if you have a lot of PVCs, they can be just as disturbing as A-Fib.

When are PVCs Dangerous?

If you experience 5+ PVCs per minute or 10-̵30 per hour, you probably should see your Electrophysiologist (EP).

To read how one patient dealt with his PVCs, see John Thorton’s story, PVC-Free After Successful Ablation at Mayo Clinic.

In particular, PVCs can be dangerous if they amount to over 20% of your heart beats. This can weaken your heart muscle. The Mayo Clinic calls them “high density PVCs”.

Can Life-Threatening PVCs be Treated?

Yes, one treatment for excessive PVCs is a PVC ablation. During this ablation the PVCs are mapped and isolated in much the same way A-Fib signals are isolated during an A-Fib ablation.

If you are looking into an ablation for your PVCs, know that not as many EPs perform PVC ablation compared to A-Fib. (Ask your EP for referrals.)

For more about A-Fib with PVCs see, FAQs Coping with A-Fib: PVCs & PACs.

Lorrie’s Catastrophic Mini-Maze Surgery and Its After-Math

Lorrie was an informed Atrial Fibrillation patient. She did everything right.

Lorrie C.

She researched her disease, she studied the choices of surgical treatments. With input from her EP, she thoughtfully decided on a Mini-Maze surgery.

She chose a highly skilled cardiac surgeon with an outstanding reputation. She and a companion interviewed the surgeon and asked loads of questions—twice. And chose one of the top 100 hospitals in the country for her surgery.

It’s a shame she had to endure so many complications.

The first part of Lorrie’s Atrial Fibrillation story was written in 2012 from her hospital room upon re-admission after Mini-Maze surgery. She then jumps to the present and writes about the aftermath. She begins:

“As I sit in my hospital bed on my seventh consecutive day of my second admission, I have finally mustered the strength and clarity of mind to write about my exasperating experience of an elective surgery… .
My A-Fib started when I was in my early 60’s with only a few episodes a year. The story of my Mini-Maze surgery began about four years later when my electrophysiologist felt it was time to put an end to my increasing episodes of Atrial Fibrillation.
Due to having paroxysmal A-Fib (meaning every now and then for unknown reasons) as well as my good health and stamina, at 66 years of age I was the perfect candidate for either a catheter vein ablation or Mini-Maze surgery. Because I was only having about 3 episodes a year and in good health, my EP felt that I would have a success rate of over 95%.
After much research, I decided the Mini-Maze would be the best procedure for me. (My EP felt it would be a better choice than an ablation, for he felt I would have a good outcome, which I did not.)
He also warned me that the Mini-Maze wouldn’t be a “walk in the park.” That was an understatement! …

…Continue reading Lorrie’s story about her mini-maze surgery and learn her advice to others with A-Fib.

Interview with Michele Straube on Results of Survey of A-Fib Patients and Wearable Devices

by Steve S. Ryan

We are happy share the results of Michele Straube’s survey of A-Fib patients on consumer wearable/portable devices/apps which many of you participated in April 2019. She received a great response―315 replies! You can review the actual survey and tabulated results at: Survey Questions and the Results.

You may want to re-read Michele Straube’s 2010 A-Fib story, Cured after 30 years in A-Fib. She recently had a second catheter ablation June 11, 2020  and is doing fine, “Went for a walk in the mountains yesterday with 500’ elevation gain, and felt good.”

Michele Straube

Interpreting the Survey Data

I asked Ms. Straube to share her insights and conclusions about her survey data and how it might or should affect A-Fib treatment strategies.

“What do you think is important in your survey’s responses?”

It’s important how many people responded, and the fact that these AFib patients are very interested in having data about their condition.

It’s clear that AFib patients are interested in being an active part of the team managing their condition. Doctors should welcome this (but see below).

For device and apps developers: there’s a huge market for wearables with apps that help inform AFib patients and gain peace of mind when making treatment decisions. Current devices don’t necessarily give us all the information we’re seeking.

There should be greater collaboration between the device developers and patients in future research and design.

Review the actual survey and tabulated results at: Survey Questions and the Results.
 “What information were you looking for?”

I wanted to know if AFib patients use wearable devices? And if so, why and how they use the data. What device or apps would they like someone to design for them.

 “Were you surprised by any of the results?”

I was surprised how many different devices there are that give some kind of relevant data (over 45 different brands), yet virtually none of the A-Fib respondents were 100% satisfied with their device’s capabilities.

About 10% of the respondents said that their doctors were not interested in seeing the data from wearable devices!!!

Many of the respondents wished for device capabilities that already exist; i.e., the devices are not being marketed to the right audience.

 “What results do you think should be published?”

I wanted to know how AFib patients currently use the data available and what they wish would be developed.

“How do you think your results should influence A-Fib treatment strategies?”

Educate: AFib patients should be educated about the various types of consumer devices and encouraged to use them to help manage their AFib.

Medical providers: doctors should welcome this independently collected additional data (especially for patients who experience AFib episodes when they’re not in the doctor’s office).

Treatment costs: A patient’s use of wearables and apps can reduce the overall expense of AFib treatment.

Michele shared how she used a wearable device:

Using myself as an example, I take an ECG reading on my device, email it to the doctor’s office, and we discuss what to do about a “bad” reading via email or phone. 

The one time my device was not working correctly, I had to go into the office for an official EKG reading, which took up much more of everyone’s time and cost oodles of money … and the end result (modification of my meds) was the exact same had I emailed a reading from my device.

We appreciate Michele’s survey work and sharing the results and her conclusions with A-Fib.com readers.

Review the actual survey and tabulated results at: Survey Questions and the Results.

Michele expressed her gratitude to all who participated in this survey, and to A-Fib.com and other sites that solicited A-Fib patients to take the survey. Michele Straube can be reached at mstraube@mindspring.com

AVNRT Diagnosed, 2nd Ablation—Finally A-Fib Free

Prior to 2015, I was an active 67-year old male who had taken up running in my late 30’s…I had never experienced any heart issues. Late in September 2015, my heart was racing and a local Spokane hospital ER informed I was experiencing atrial fibrillation. Approximately 12 hours later, with meds, I was back in normal sinus rhythm.

Bob Thompson, Spokane, WA

Over Three Years A-Fib, Bouts Become More Frequent

Over the next few years, I went into A-Fib over 50 times with each bout lasting on the average 10 to 12 hours.Taking metoprolol while in A-Fib, got me back in normal sinus rhythm. I never needed to have a cardioversion.

After dealing with A-Fib for over three years and with the occurrences becoming more frequent, I opted to have a heart catheter ablation in September 2018. Result: the ablation was a complete failure. The EP was only able to ablate three of the four pulmonary veins.

Ablation Fails—Exploring Mini-Maze Procedure

After my failed ablation, my occurrences of A-Fib rapidly increased. I began to explore another option, a mini-maze procedure.

The cardiac surgeon in Spokane suggested I try one more catheter ablation before I opted for the mini-maze procedure.

I met with a cardiac surgeon in Spokane who suggested I try one more catheter ablation before I opted for the mini-maze procedure. The surgeon informed me that the best EP in Spokane was Dr. Mark Harwood whom he would be seeing later in the day.

Best EP in Spokane Calls Me the Next Day!

One day after meeting with the cardiac surgeon, I received a call from Dr. Harwood’s office. Upon meeting with Dr. Harwood, he informed me that he was confident of his ability to ablate all four of my pulmonary veins.

Scheduled for Ablation But Stress Test Reveals AVNRT

I was scheduled to have my second ablation in March 2019, but it was contingent on the results of a stress test.

A few days later, at the end of the stress test, I went into A-Fib. An irregularity (tachycardia) was detected requiring an AVNRT Ablation as well. Continue reading Bob’s story…->

After 50 years of Irregular Heartbeats and PVCs, Finally an A-Fib Diagnosis and Treatment

Cecelia Hender, 72, shares about her life with Atrial Fibrillation. She writes that heart arrhythmias have been a part of her life since she was a young woman.

I was about 20 years old when I first experienced irregular heartbeats. My doctor back then told me it was “nerves” and to relax.

This was how most women were treated by doctors back then. Everything was “nerves”.

Cecelia Hender from Abington, MA with her granddaughter.

In my 30’s, I told another doctor how my heart would take off like a race horse, I could not breathe. He said, “try not to think about it.”  What????

I fought with these irregular heartbeats for many years. I was never told to see a cardiologist or have a doctor investigate just what was going on.

Sent to a Cardiologist Almost By Accident

About 15 years ago, I worked for a medical facility, and one day a young doctor came in and was waiting for an interview…when he said he was an electrophysiologist [cardiac specialist], I asked about my irregular heartbeats.

He was so kind and intelligent…It was this young doctor who told me that I should see a cardiologist. So, I did. And I was treated with medications and wore many heart monitors.

Hard to Document the Arrhythmia

But it was always hard to catch the arrhythmias on an ECG or heart monitor.

My whole life was spent afraid and never going anywhere alone for fear that my heart would act up and I’d be stranded someplace unable to breathe – unable to move. 

Finally, in 2017 I had another [heart] monitor, and it showed a series of irregular heartbeats.

But on this one particular day, I had a very irritating rhythm. It was very fast, then irregularly fast, and I could barely breathe. I went to my PCP [Primary Care Physician] office where they did an EKG and said, “You are in A-Fib”.

They sent me immediately to my cardiologist who confirmed this. I was put on a different kind of med (Metoprolol at first and also Coumadin). And “fingers crossed” I would convert on my own. It took almost two weeks…Continue to read how two ablations brought Cecelia Hender relief from A-Fib and PVCs, and about a recent setback ->

Follow Us
facebook - A-Fib.comtwitter - A-Fib.comlinkedin  - A-Fib.compinterest  - A-Fib.comYouTube: A-Fib Can be Cured!  - A-Fib.com

A-Fib.com Mission Statement

We Need You

Encourage others
with A-Fib
click to order.


A-Fib.com is a
501(c)(3) Nonprofit



Your support is needed. Every donation helps, even just $1.00.



A-Fib.com top rated by Healthline.com since 2014 

Home | The A-Fib Coach | Help Support A-Fib.com | A-Fib News Archive | Tell Us What You think | Press Room | GuideStar Seal | HON certification | Disclosures | Terms of Use | Privacy Policy